January 2019 saw the launch of the EU research project EDCMET, in which scientists from the German Federal Institute for Risk Assessment (BfR) are also involved.
January 2019 saw the launch of the EU research project EDCMET, in which scientists from the German Federal Institute for Risk Assessment (BfR) are also involved. EDCMET stands for "Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome path-ways" and is aimed at developing methods to identify chemical compounds that disrupt metabolic processes in the body. At the same time, the research project will also be pinpointing biochemical mechanisms that trigger these disruptions. "The identification of these kinds of endocrine disruptors and their impact on bodily functions is a central aspect of the risk assessment of chemicals", says BfR President Professor Dr. Dr. Andreas Hensel, "and the reliable detection of these effects using validated methods therefore plays an essential role in drawing up legal regulations." In the context of the research project EDCMET, the researchers at the BfR will use cell culture systems and animal models to explore how chemicals affect fat and energy metabolism in liver cells. The aim of the EU project is to develop and validate test systems to the stage where they are suitable for the routine testing of chemicals in the field of regulatory toxicology.
Endocrine disruptors is the name given to compounds that disrupt the hormone-controlled signal pathways and negatively impact health. These substances are also suspected of involvement in the development of metabolic diseases such as obesity, fatty liver, high cholesterol levels in the blood and diabetes. There has been very little research conducted to date as to whether and by what route endocrine disruptors influence these metabolic processes. Consequently, no validated methods exist for the assessment of their metabolic effect.
Read more at BFR Federal Institute for Risk Assessment